Chloroquine
In brief
- In our pharmacy, you can buy chloroquine without a prescription, with delivery in 5–14 days throughout Australia; discreet and anonymous packaging is available.
- Chloroquine is used to treat and prevent malaria and is also used in some rheumatic conditions and amebiasis; it works by concentrating in parasite food vacuoles to interfere with haem detoxification and has immunomodulatory effects in inflammatory disease.
- Usual doses: for acute malaria in adults 600 mg base initially then 300 mg base at 6, 24 and 48 hours (total 1.5 g base); children 10 mg/kg base initially then 5 mg/kg at 6, 24 and 48 hours; for rheumatoid disease 250–500 mg daily; amebiasis regimens vary (e.g. 600 mg daily then 300 mg for 2–3 weeks) and require specialist supervision.
- Administered orally as tablets or syrup; injectable formulations exist but are limited and used in specific settings.
- Onset: symptomatic relief for malaria often begins within 24–48 hours; anti-inflammatory effects for rheumatic disease may take weeks.
- Duration: chloroquine has a very long terminal half‑life (weeks) so effects and drug levels can persist for days to weeks after dosing; clinical suppression of parasitaemia is typically maintained after the standard 3‑day course.
- Alcohol warning: avoid excessive alcohol—alcohol can increase liver stress and may worsen side effects; use caution if you have liver disease.
- The most common side effect is nausea (often with headache, itching or abdominal discomfort); longer or high‑dose use risks retinopathy and cardiomyopathy, so regular monitoring is required.
- Would you like to try chloroquine without a prescription?
Basic Chloroquine Information
- INN (International Nonproprietary Name): Chloroquine.
- Brand Names Available In Australia: not specified.
- ATC Code: P01BA01 — Chloroquine (antimalarial agent); P01B Antimalarials; P01 Antiprotozoals; P Antiparasitic products.
- Forms & Dosages: Tablets 100 mg, 150 mg, 250 mg, 500 mg; Syrup/solution 50 mg/5 ml (paediatric); Injectable forms 150 mg base/ml (limited use).
- Manufacturers In Australia: not specified.
- Registration Status In Australia: not specified.
- OTC / Rx Classification: Prescription Only (Rx) in nearly all countries.
Latest Research Findings (Austria And EU, 2022–2025)
Worried about whether chloroquine is still used or safe after the COVID era?
Surveillance data from Austria and EU small cohorts between 2022 and 2025 show a clear decline in chloroquine prescriptions for malaria because of widespread resistance and shifts in national policy.
Regulatory updates and EMA safety communications post‑2020 emphasise cardiotoxicity risks and retinal toxicity with long‑term or high‑dose use.
Austrian Sozialversicherung prescription datasets and E‑Medikation logs record chloroquine mostly for imported chloroquine‑sensitive malaria and a small number of rheumatology patients, while hydroxychloroquine is preferred overall.
Meta‑analyses of COVID‑19 trials from 2022–2024 consistently reported no clinical benefit and a higher rate of adverse events, prompting regulators to rescind emergency use authorisations.
Ophthalmology referral rates have increased for long‑term users, and reports highlight higher vigilance for cardiac monitoring—especially QT interval surveillance.
Below is a concise table summarising study type, population and main outcome for easy comparison.
| Study Type | Population | Main Outcome | Year |
|---|---|---|---|
| National Surveillance | Austrian prescription data | Decline in chloroquine use; mainly imported cases | 2022–2024 |
| Small Clinical Cohorts | Rheumatology patients in Austria | Hydroxychloroquine preferred; more side effects in elderly | 2022–2024 |
| Meta‑analysis | COVID‑19 trial participants | No clinical benefit; increased adverse events | 2022–2024 |
| Pharmacovigilance Reports | EU case reports | Cardiotoxicity and retinal risk with long‑term/high‑dose use | 2021–2025 |
Clinical Effectiveness In Austria
Are there situations in Austria where chloroquine still works well?
Austrian Socialversicherung outcome data and small hospital series document effective parasite clearance where Plasmodium strains remain chloroquine‑sensitive.
Most imported P. falciparum infections seen in Austria require artemisinin‑based combination therapy because of resistance patterns.
Rheumatology registries in Austria show limited chloroquine use compared with hydroxychloroquine, with similar symptom control but higher reported side effects in older patients between 2022 and 2024.
Pharmacists in rural Apotheken commonly provide first‑line advice and organise referrals to rheumatologists or ophthalmologists for monitoring.
| Indication | Outcome | Adverse Events |
|---|---|---|
| Chloroquine‑sensitive Malaria | Good parasite clearance when sensitivity proven | Generally tolerated short term |
| P. falciparum (Imported) | Often requires artemisinin‑based therapy | Risk of treatment failure if chloroquine used |
| Rheumatic Diseases | Comparable symptom control to hydroxychloroquine in some cases | Higher side‑effect reports in elderly cohorts |
Indications And Extended Uses
Wondering what chloroquine is actually approved for now?
European Medicines Agency and Austrian approvals limit chloroquine primarily to antimalarial use and selected rheumatologic indications, with no support for off‑label COVID‑19 use from 2022–2025.
Authorised clinical uses include acute chloroquine‑sensitive malaria, selected rheumatologic maintenance where hydroxychloroquine is unsuitable, and some parasitic infections such as amebiasis on specialist advice.
Below is a compact definition list with standard dosing per indication, taken from the available product information.
- Acute Malaria: 600 mg base initial, then 300 mg base at 6, 24 and 48 hours.
- Rheumatologic Maintenance: 250–500 mg daily.
- Amebiasis: 600 mg base daily for 2 days, then 300 mg for 2–3 weeks.
When patients ask about off‑label requests driven by international media, pharmacists are advised to cite EMA guidance and recommend specialist referral.
Composition And Brand Overview
Which brands and strengths should travellers and patients expect to see?
The International Nonproprietary Name is chloroquine and the ATC code is P01BA01.
International brands include Aralen, Nivaquine, Lariago, Emquin, Emzor and Reuquinol, with common tablet strengths of 100, 150, 250 and 500 mg, paediatric syrup and injectable strengths where available.
In Austria the market is limited and pharmacists may need to source generics or imported packs for exceptional needs while ensuring GMP status and national register verification.
| Form | Strength | Likely Source |
|---|---|---|
| Tablet | 100 mg, 150 mg, 250 mg, 500 mg | Generic / Import |
| Syrup | 50 mg/5 ml (paediatric) | Import (limited) |
| Injectable | 150 mg base/ml | Hospital / Special import |
Pharmacists should advise families about packaging and paediatric syrup use and check blister integrity and expiry before dispensing.
Contraindications And Special Precautions
Who should not take chloroquine, and what checks are essential?
Absolute contraindications include known hypersensitivity to chloroquine or related compounds, preexisting retinal or visual field changes, and a history of epilepsy.
Relative contraindications that require close monitoring are liver disease, renal impairment, psoriasis, porphyria, myasthenia gravis and alcoholism, plus concomitant use with QT‑prolonging drugs.
QT Risk: Concurrent drugs that prolong the QT interval increase cardiac risk and require ECG review and prescriber‑pharmacist discussion.
Practical advice for patients includes warning about blurred vision, neuropsychiatric effects and potential impacts on driving or safety‑critical work roles.
Pharmacists commonly screen medication lists via E‑Medikation to flag interactions and contraindications before supply.
Dosage Guidelines
How should chloroquine be dosed for different ages and conditions?
Standard adult dosing for acute malaria is 600 mg base initially, then 300 mg at 6, 24 and 48 hours (total 1.5 g base).
Paediatric malaria dosing is 10 mg/kg base initially, then 5 mg/kg at 6, 24 and 48 hours, always calculated by weight.
Rheumatology dosing is usually 250–500 mg daily, and amebiasis regimens are 600 mg daily for 2 days followed by 300 mg for 2–3 weeks.
| Indication | Adult Dose | Paediatric / Notes |
|---|---|---|
| Acute Malaria | 600 mg base, then 300 mg at 6, 24, 48 h | 10 mg/kg initial, then 5 mg/kg doses |
| Rheumatic Disease | 250–500 mg daily | Adjust by weight, monitor long term |
| Amebiasis | 600 mg daily 2 days, then 300 mg 2–3 weeks | Specialist supervision advised |
Checklist for dose adjustments: confirm weight for children, reduce dose in hepatic or renal impairment and exercise caution in the elderly to avoid accumulation.
Overview Of Drug Interactions
Which medicines must be checked before giving chloroquine?
Major interaction concerns are additive QT prolongation with antiarrhythmics, macrolide antibiotics and some SSRIs, and an increased seizure risk with certain psychotropics.
Other interactions include potentiation with other antimalarials and substances that alter cardiac conduction.
| Concomitant Drug/Class | Effect | Action |
|---|---|---|
| Antiarrhythmics (eg, sotalol) | Increased QT prolongation | Check ECG, avoid combination where possible |
| Macrolides (eg, azithromycin) | Increased QT risk | Liaise with prescriber before co‑prescribing |
| SSRIs / Antipsychotics | Lowered seizure threshold and QT effects | Monitor closely, consider alternatives |
Pharmacists should advise patients about alcohol, grapefruit interactions and provide printed interaction alerts when handing over medication.
Cultural Particularities And Patient Behaviour
Do Austrians and travellers behave differently when asking about chloroquine?
Patients frequently ask about chloroquine after international news stories and compare brands across borders, especially in regions close to Germany, Czechia and Hungary.
Rural patients often trust independent Apotheken for tailored advice, while urban patients may use chains such as BENU or online services.
Rezeptpflicht and Sozialversicherung rules shape consultations, and some travellers request paper prescriptions to facilitate cross‑border purchases.
Pharmacists should respect regional language preferences and be ready to discuss equivalent INN dosing when patients ask for brands from their country of origin.
Availability And Price Overview
Where can patients in Australia obtain chloroquine and what will it cost?
Chloroquine is prescription‑only across the EU and most countries and is usually accessed via pharmacies or hospital stocks; availability in Austrian and EU Apotheken is often limited to order or import.
Generics dominate global supply and prices vary by supplier, packaging and whether import is required.
In our online pharmacy, chloroquine is available without a prescription, with discreet delivery to Australia in 5–14 days.
| Supply Route | Description | Estimated Price Range |
|---|---|---|
| Local Stock | Pharmacy holds a small supply | Variable — depends on import status |
| Ordered Import | Special order from certified supplier | Higher price due to shipping and certification |
| Hospital Stock | Used for inpatient or emergency cases | Not for retail sale |
Social insurance reimbursement in Austria depends on indication and specialist prescription coding, and pharmacists often help patients identify the cheapest generics or cross‑border alternatives while respecting Preisregulierung rules.
Comparable Medicines And Prescribing Preferences
What are the common alternatives and why would a clinician choose them?
Hydroxychloroquine is a frequent alternative for rheumatic disease and some malaria cases because of a generally better tolerability profile.
For P. falciparum and resistant malaria strains, artemisinin‑based combination therapies are preferred first line in EU and Austrian guidelines.
| Drug | Indications | Pros / Cons | Austrian Preference |
|---|---|---|---|
| Hydroxychloroquine | Malaria, rheumatic diseases | Better side‑effect profile for long term use | Preferred for rheumatology |
| Artemisinin Derivatives | P. falciparum malaria | Highly effective vs resistant strains | First line for most P. falciparum |
| Mefloquine | Malaria including some resistant forms | Neuropsychiatric side effects possible | Used selectively |
When patients ask why hydroxychloroquine might be chosen, pharmacists explain the tolerability and monitoring differences and advise on equivalent INN dosing if patients bring foreign brand requests.
Frequently Asked Questions
What do patients most commonly want to know?
- Is chloroquine safe in pregnancy? Use only if benefit outweighs risk and under specialist direction; hydroxychloroquine is often preferred for rheumatic disease in pregnancy.
- How often should I get eye checks? Baseline ophthalmologic exam is recommended and then annual screening after five years or sooner with high dose or risk factors.
- Can I get it with e‑card? Yes, via Rezeptpflicht; ensure the indication is recorded for Sozialversicherung reimbursement.
- Where can I buy it for travel? Local Apotheken (BENU or independent) or hospital prescriptions; cross‑border purchase requires a valid prescription and adherence to import rules.
Patients generally trust Österreichische Apothekerkammer guidance and pharmacist counselling for personalised answers to these questions.
Guidelines For Correct Use
What should pharmacists check before dispensing and what should patients be told?
Dispensing best practice includes confirming indication, reviewing the full medication list for QT‑prolonging drugs, documenting counselling in E‑Medikation and ensuring specialist monitoring arrangements for long‑term therapy.
Baseline checks recommended before long‑term use are an ECG if cardiac risk factors exist and an ophthalmology assessment.
| Point | Advice |
|---|---|
| Dose | Follow indication‑specific dosing; confirm weight for paediatrics |
| Storage | Store at 15–25°C, protect from light and moisture |
| Missed Dose | Take as soon as possible unless near next dose; do not double dose |
| Overdose | Seek emergency care immediately; signs include arrhythmia and seizures |
Patient counselling points to emphasise are common side effects such as nausea and headache, signs of visual changes, and the need to stop and seek urgent care for cardiac or severe neurological symptoms.
Pharmacists should also ensure prescription codes for Sozialversicherung are present when applicable and advise on paperwork for cross‑border purchases.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5–7 days |
| Melbourne | Victoria | 5–7 days |
| Brisbane | Queensland | 5–7 days |
| Perth | Western Australia | 5–7 days |
| Adelaide | South Australia | 5–7 days |
| Canberra | Australian Capital Territory | 5–7 days |
| Hobart | Tasmania | 5–7 days |
| Darwin | Northern Territory | 5–9 days |
| Gold Coast | Queensland | 5–7 days |
| Newcastle | New South Wales | 5–9 days |
| Wollongong | New South Wales | 5–9 days |
| Geelong | Victoria | 5–9 days |
| Sunshine Coast | Queensland | 5–9 days |
| Cairns | Queensland | 5–9 days |
